Moccia, Marcello http://orcid.org/0000-0003-2613-3090
Affinito, Giuseppina
Berera, Giulia
Marrazzo, Giuseppina
Piscitelli, Raffaele
Carotenuto, Antonio
Petracca, Maria
Lanzillo, Roberta
Triassi, Maria
Brescia Morra, Vincenzo
Palladino, Raffaele
Funding for this research was provided by:
Roche (2021)
Article History
Received: 13 June 2022
Revised: 27 July 2022
Accepted: 1 August 2022
First Online: 11 August 2022
Declarations
:
: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by Roche SpA, Monza, Italy, on the basis of a Sponsored Research Agreement. Marcello Moccia has received research grants from ECTRIMS-MAGNIMS, UK MS Society, and Merck; honoraria from Biogen, BMS Celgene, Merck, Roche, and Sanofi-Genzyme. Antonio Carotenuto has received research grants from Almirall, research grants from ECTRIMS-MAGNIMS and honoraria from Almirall, Biogen, Roche Sanofi-Genzyme and Novartis. Maria Petracca has received research grants from Italian MS Foundation and Baroni Foundation, honoraria from HEALTH&LIFE S.r.l. and Biogen and sponsorship for travel/meeting expenses from Novartis, Roche and Merck. Roberta Lanzillo has received honoraria from Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. Vincenzo Brescia Morra has received research grants from the Italian MS Society, and Roche; and honoraria from Bayer, Biogen, Merck, Mylan, Novartis, Roche, Sanofi-Genzyme, and Teva. Other authors have nothing to disclose.
: The study was approved by the Federico II Ethics Committee (355/19).The study was performed in accordance with good clinical practice and Declaration of Helsinki.